BioXcel Therapeutics Inc
NASDAQ:BTAI
BioXcel Therapeutics Inc
NASDAQ:BTAI
Price:
1.415 USD
-4.39%
Market Closed
Updated:
Jun 9, 2024
BioXcel Therapeutics Inc
Other Current Assets
|
BioXcel Therapeutics Inc
Other Current Assets Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Other Current Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
BioXcel Therapeutics Inc
NASDAQ:BTAI
|
Other Current Assets
$4m
|
CAGR 3-Years
12%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Other Current Assets
$4.6B
|
CAGR 3-Years
5%
|
CAGR 5-Years
21%
|
CAGR 10-Years
6%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Current Assets
$2.8B
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Current Assets
$2.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-1%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Current Assets
$511.1m
|
CAGR 3-Years
15%
|
CAGR 5-Years
31%
|
CAGR 10-Years
31%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Current Assets
$414.9m
|
CAGR 3-Years
25%
|
CAGR 5-Years
18%
|
CAGR 10-Years
17%
|
See Also
What is BioXcel Therapeutics Inc's Other Current Assets?
Other Current Assets
4m
USD
4m
USD
Based on the financial report for Mar 31, 2024, BioXcel Therapeutics Inc's Other Current Assets amounts to 4m USD.
What is BioXcel Therapeutics Inc's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
17%
17%
Over the last year, the Other Current Assets growth was -58%. The average annual Other Current Assets growth rates for BioXcel Therapeutics Inc have been 12% over the past three years , 17% over the past five years .
You don't have any saved screeners yet
